Noninvasive tests for liver fibrosis in 2024:are there different scales for different diseases?Jimmy Che-To Lai, Lilian Yan Liang, Grace Lai-Hung Wong517-531
Preoperative risk evaluation and optimization for patients with liver diseaseSameer Bhalla, Brendan Mcquillen, Edward Cay, Nancy Reau532-543
Advances in the management of complications from cirrhosisJasleen Singh, Mark Ebaid, Sammy Saab544-555
Postpartum hepatitis flares in mothers with chronic hepatitis B infectionShi OuYang, Yawen Geng, Gongqin Qiu, Yueying Deng, Haitao Deng, Calvin Q.Pan556-567
New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradicationCalvin Q.Pan, Andrew J.Park, James S.Park568-574
Active role of the immune system in metabolic dysfunction-associated steatotic liver diseaseTaizo Mori, Sachiyo Yoshio, Eiji Kakazu, Tatsuya Kanto575-585
Advances in the management of alcohol-associated liver diseaseAhmad Anouti, Thomas A.Kerr, Mack C.Mitchell, Thomas G.Cotter586-601
Independent and additive effects of binge drinking and obesity on liver enzymes:a cross-sectional analysis using the Korean National Health Insurance Service dataAnthony Kityo, Sang-Ah Lee602-609
Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients:a retrospective cohort studyZixuan Li, Xiaoying Wu, Zebin Chen, Xiuqing Wei, Weiqing Chen610-615
